This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Williams ED, Sandler M. The classification of carcinoid tumours. Lancet. 1963;1: 238-239.14000847WilliamsEDSandlerM.The classification of carcinoid tumours1963123823910.1016/S0140-6736(63)90951-6Search in Google Scholar
Yao JC, Hassan M, Phan A et al. One hundred years after «carcinoid»: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825cases in the United States. J Clin Oncol. 2008; 26: 3063-30721856589410.1200/JCO.2007.15.4377YaoJCHassanMPhanAOne hundred years after «carcinoid»: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825cases in the United States2008263063307218565894Search in Google Scholar
https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdfhttps://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdfSearch in Google Scholar
Niklas Gebauer, Christian Schmidt-Werthern, Veronica Bernard et al.Genomic landscape of pancreatic neuroendocrine tumors. World J Gastroenterol 2014 December 14; 20(46): 17498-175062551666410.3748/wjg.v20.i46.17498NiklasGebauerChristianSchmidt-WerthernVeronicaBernardGenomic landscape of pancreatic neuroendocrine tumors2014December 1420461749817506426561125516664Search in Google Scholar
Joakim Crona, Britt Skogseid. Genetics of neuroendocrine tumors. European Journal of Endocrinology(2016) 174, R275–R290JoakimCronaBrittSkogseidGenetics of neuroendocrine tumors2016174R275R29010.1530/EJE-15-097227165966Search in Google Scholar
Ken-Shwo Dai, Wei Wei, Choong-Chin Liew. Molecular Cloning and Characterization of a Novel Human Gene Containing Ankyrin Repeat and Double BTB/POZ Domain. Biochemical and Biophysical Research Communications 273, 991– 996 (2000)10.1006/bbrc.2000.305310891360Ken-ShwoDaiWeiWeiChoong-ChinLiewMolecular Cloning and Characterization of a Novel Human Gene Containing Ankyrin Repeat and Double BTB/POZ Domain273991996200010891360Open DOISearch in Google Scholar
Pérez-Magán E, Rodríguez de Lope A, Ribalta T et al. Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas. Neuro Oncol 2010; 12: 1278-12902068572010.1093/neuonc/noq081Pérez-MagánERodríguez de LopeARibaltaTDifferential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas20101212781290301893720685720Search in Google Scholar
Jen J1, Lin LL2, Chen HT3 et al. Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer. Oncogene,2016 May 5;35(18):2357-692627930410.1038/onc.2015.296JenJ1LinLL2ChenHT3Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer2016May 53518235769486547526279304Search in Google Scholar
Aragane H, Sakakura C, Nakanishi M et al. Chromosomal aberrations in colorectal cancersand liver metastases analyzed by comparative genomic hybridization. Int J Cancer 2001; 94: 623-6291174545510.1002/ijc.1522AraganeHSakakuraCNakanishiMChromosomal aberrations in colorectal cancersand liver metastases analyzed by comparative genomic hybridization20019462362911745455Search in Google Scholar
Schmidt H, Taubert H, Würl P et al. Gains of 12q are the most frequent genomic imbalances in adult fibrosarcoma and are correlated with a poor outcome. Genes Chromosomes Cancer 2002; 34: 69-7710.1002/gcc.1003611921284SchmidtHTaubertHWürlPGains of 12q are the most frequent genomic imbalances in adult fibrosarcoma and are correlated with a poor outcome200234697711921284Open DOISearch in Google Scholar
Hale JS, Li M, Sinyuk M, Jahnen-Dechent W et al. Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesisand growth. PLoS One 2012; 7: e4003310.1371/journal.pone.0040033HaleJSLiMSinyukMJahnen-DechentWContext dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesisand growth20127e40033339373422808089Open DOISearch in Google Scholar
May P, May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 1999, 18 (53): 7621–361061870210.1038/sj.onc.1203285MayPMayE.Twenty years of p53 research: structural and functional aspects of the p53 protein1999185376213610618702Search in Google Scholar
Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009; 137: 413-4311941054010.1016/j.cell.2009.04.037VousdenKHPrivesC.Blinded by the Light: The Growing Complexity of p53200913741343119410540Search in Google Scholar
Marinoni I, Kurrer AS, Vassella E et al. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors. Gastroenterology 2014, 146, 453–460.10.1053/j.gastro.2013.10.02024148618MarinoniIKurrerASVassellaELoss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors201414645346024148618Open DOISearch in Google Scholar
Lovejoy CA, Li W, Reisenweber S et al. Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genetics 2012 8.LovejoyCALiWReisenweberSLoss of ATRX genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway2012810.1371/journal.pgen.1002772340058122829774Search in Google Scholar
Jonkers YM, Claessen SM, Perren A et al. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients. Endocrine-Related Cancer 2007 14 769–779.10.1677/ERC-07-011117914106JonkersYMClaessenSMPerrenADNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients20071476977917914106Open DOISearch in Google Scholar
Guertin DA, Sabatini DM . Defining the role of mTOR in cancer. Cancer Cell 2009, 12 (1): 9–22.GuertinDASabatiniDM.Defining the role of mTOR in cancer200912192210.1016/j.ccr.2007.05.00817613433Search in Google Scholar
Verger A, Duterque-Coquillaud M. When Ets transcription factors meet their partners. Bioessays. 2002 Apr;24(4):362-70.10.1002/bies.1006811948622VergerADuterque-CoquillaudM.When Ets transcription factors meet their partners2002Apr2443627011948622Open DOISearch in Google Scholar
Li YX, Jin HG, Yan CG et al. Molecular cloning, sequence identification, and gene expression analysis of bovine ADCY2 gene. Mol Biol Rep. 2014 Jun;41(6):3561-810.1007/s11033-014-3167-924797538LiYXJinHGYanCGMolecular cloning, sequence identification, and gene expression analysis of bovine ADCY2 gene2014Jun4163561824797538Open DOISearch in Google Scholar
Sacchetti P, Carpentier R, Ségard P et al. Multiple signaling pathways regulate the transcriptional activity of the orphan nuclear receptor NURR1. Nucleic Acids Res. 2006;34(19):5515-2710.1093/nar/gkl71217020917SacchettiPCarpentierRSégardPMultiple signaling pathways regulate the transcriptional activity of the orphan nuclear receptor NURR120063419551527163649017020917Open DOISearch in Google Scholar
Lee D, Sohn H, Kalpana GV et al. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA. Nature 399 (6735): 487–91036596310.1038/20966LeeDSohnHKalpanaGVInteraction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA3996735487910365963Search in Google Scholar
Le Tourneau C, Paoletti X, Servant N, et al. Randomised proof-of-conceptphase II trial comparing targeted therapy based on tumour molecularprofiling vs conventional therapy in patients with refractory cancer: results ofthe feasibility part of the SHIVA trial. Br J Cancer. 2014; 111: 17-24.10.1038/bjc.2014.211Le TourneauCPaolettiXServantNRandomised proof-of-conceptphase II trial comparing targeted therapy based on tumour molecularprofiling vs conventional therapy in patients with refractory cancer: results ofthe feasibility part of the SHIVA trial20141111724Open DOISearch in Google Scholar
Sanchez-Cespedes M. A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome. Oncogene 2007 26 (57): 7825–32.10.1038/sj.onc.121059417599048Sanchez-CespedesM.A role for LKB1 gene in human cancer beyond the Peutz-Jeghers syndrome20072657782532Open DOISearch in Google Scholar
Knowles PP, Murray-Rust J, Kjaer S et al. Structure and chemical inhibition of the RET tyrosine kinase domain. J Biol Chem. 2006 Nov 3;281(44):33577-871692868310.1074/jbc.M605604200KnowlesPPMurray-RustJKjaerSStructure and chemical inhibition of the RET tyrosine kinase domain2006Nov 3281443357787Search in Google Scholar
Xiao-Ping Qi,1,* Ju-Ming Ma,1 Zhen-Fang Du et al. RET Germline Mutations Identified by Exome Sequencing in a Chinese Multiple Endocrine Neoplasia Type 2A/Familial Medullary Thyroid Carcinoma Family. PLoS One. 2011; 6(5): e20353.10.1371/journal.pone.0020353Xiao-PingQi,1,*Ju-MingMa,1Zhen-FangDuRET Germline Mutations Identified by Exome Sequencing in a Chinese Multiple Endocrine Neoplasia Type 2A/Familial Medullary Thyroid Carcinoma Family201165e20353Open DOISearch in Google Scholar
Park C, Ha SY, Kim ST et al. Identification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors. Oncotarget. 2016 Jan 26;7(4):4024-3510.18632/oncotarget.660226684240ParkCHaSYKimSTIdentification of the BRAF V600E mutation in gastroenteropancreatic neuroendocrine tumors2016Jan 2674402435Open DOISearch in Google Scholar
Lew DJ, Dulic V, Reed SI. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell. 1991 Sep 20;66(6):1197-206.183306610.1016/0092-8674(91)90042-WLewDJDulicVReedSI.Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast1991Sep 206661197206Search in Google Scholar